Johnson & Johnson Revives Interest in Respiratory Drugs Research
By Debbie Tranter
Pharma Deals Review: Vol 2010 Issue 6 (Table of Contents)
Published: 18 Jun-2010
DOI: 10.3833/pdr.v2010.i6.1352 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Johnson & Johnson (J&J), through its subsidiaries, has inked two successive deals for preclinical compounds to treat respiratory diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS